Structure | Chemical Name | CAS | MF |
|
ANTIMONY STANDARD 1,00 G SB
|
|
Sb
|
|
ANTI-MOUSE V-BETA 5.1, 5.2 TCR, PE
|
|
|
|
Antimony121
|
14265-72-6
|
Sb
|
|
Antimony123
|
14119-16-5
|
Sb
|
|
Antimony oxide (Sb2O3), reaction products with talc
|
127153-81-5
|
|
|
ANTI-MOUSE CD124, PE
|
|
|
|
ANTI-MOUSE PAN-NK CELLS
|
|
|
|
ANTI-MMP 7
|
|
|
|
ANTI-MOUSE TNF, APC
|
|
|
|
ANTI-MMP-14, HEMOPEXIN-LIKE DOMAIN
|
|
|
|
ANTI-MOUSE P53 BIOTIN CONJUGATE, (AA 85-109)
|
|
|
|
ANTI-MRP (QCRL-3), HUMAN
|
|
|
|
ANTI-MOUSE CD69 (VERY EARLY ACTIVATION ANTIGEN)
|
|
|
|
ANTI-MHC, CLASS II I-ED,J,K,P,R,U,V, MOUSE, FITC
|
|
|
|
ANTI-MOUSE CD49B
|
|
|
|
Antimolding In Paint
|
|
|
|
ANTI-MOUSE ALPHAE FITC
|
|
|
|
ANTI-MOUSE CD61
|
|
|
|
ANTIMONYOXIDES
|
|
|
|
ANTI-MOUSE BCM1, FITC
|
|
|
|
ANTIMONY TIN OXIDE NANOPOWDER 99.5+%
|
128221-48-7
|
H4OSbSn
|
|
ANTIMONY PENTASULFIDE
|
1315-04-4
|
H2SSb
|
|
ANTI-MOUSE IGG (FC SPECIFIC) DEVELOPED*I N GOAT AFFI
|
|
|
|
ANTI-MOUSE CCL8
|
|
|
|
ANTI-MC5
|
|
|
|
ANTI-MOUSE CD8A PE/CY5 CONJUGATED
|
|
|
|
ANTI-MOUSE CD45RB, FITC
|
|
|
|
ANTI-MOUSE IGE (EPSILON CHAIN SPECIFIC)
|
|
|
|
ANTI-MURINE CCL2
|
|
|
|
ANTI-MOUSE B7-H1, PE
|
|
|
|
ANTIMONYPLASMAEMISSIONSTANDARD,1ML=10MGSB
|
|
|
|
ANTI-MOUSE IGF BINDING PROTEIN-3, BIOTIN
|
|
|
|
ANTI-MOUSE VEGF
|
|
|
|
ANTI-MOUSE TNF RI EXTRACELLULAR DOMAIN
|
|
|
|
ANTI-MOUSE IGM BIOTIN CONJUGATE
|
|
|
|
ANTIMONY ATOMIC ABSORPTION STD. SOLN.
|
|
Sb
|
|
ANTIMONYLTARTRATES
|
|
|
|
ANTI-MALATE DEHYDROGENASE, PEROXIDASE
|
|
|
|
ANTI-MOUSE IGG, IGA, IGM (HEAVY), PEROXIDASE
|
|
|
|
ANTI-MOUSE TNF-A, CLONE V1Q
|
|
|
|
ANTI-MOUSE ID3
|
|
|
|
ANTI-MOUSE ICOS
|
|
|
|
ANTI-MOUSE IGG (GAMMA) TEXAS RED
|
|
|
|
Antimony tin oxide, NanoTek S1200W, 50% in H{2}O, colloidal dispersion
|
|
|
|
ANTIMONY ACETYLACETONATE
|
25751-57-9
|
C15H21O6Sb
|
|
antimony acid sulfide
|
|
|
|
antimony pentrachlo ride
|
|
|
|
Anti-MC2
|
|
|
|
Anti-MC3
|
|
|
|
Anti-MAO-A
|
|
|
|
Anti-MAO-B
|
|
|
|
Antimony Sodium Thioglycollate
|
539-54-8
|
C4H6NaO4S2Sb
|
|
Antimony, methylated 4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]benzenamine tannin complexes
|
68989-19-5
|
|
|
Antimony oxide (Sb2O3), mixed with arsenic oxide (As2O3)
|
68951-38-2
|
As2H6O6Sb2
|
|
ANTI-MOUSE IGG, IGA, IGM (HEAVY)
|
|
|
|
ANTI-MATRIX METALLOPROTEINASE-23 (MMP-23), N-TERMINAL
|
|
|
|
Antimony doped Tin oxide
|
|
Sb
|
|
ANTI-MOUSE SCF BIOTINYLATED POLYCLONAL ANTIBODY
|
|
|
|
ANTI-MAP KINASE, NON-PHOSPHORYLATED-ERK
|
|
|
|
ANTI-MEASLES, MATRIX PROTEIN
|
|
|
|
ANTI-MOUSE IGG3 FITC CONJUGATE
|
|
|
|
ANTI-MAML1
|
|
|
|
ANTI-MOUSE CD45.1, 45.2 FITC CONJUGATE
|
|
|
|
ANTIMONYANDCOMPOUNDS
|
|
|
|
antimony triiodide
|
64013-16-7
|
I3Sb
|
|
Antimony(III) Oxide
|
1327-33-9
|
O3Sb2
|
|
Antimony:6N and 5N purity with ingot and shot
|
|
Sb
|
|
Antimony Trioxide:5N
|
|
O3Sb-
|
|
Antimony:MBE grade 7N and 6N5 purity shaped ingots and shot
|
|
Sb
|
|
ANTIMONY, STANDARD SOLUTION 1000 MG/L SB FOR ICP (ANTIMONY IN HYDROCHLORIC ACID 10%)
|
|
Sb
|
|
Antimony: 7N, 6N5, 6N
|
|
|
|
ANTIMONY, STANDARD SOLUTION 1000 MG/L SB FOR AA (ANTIMONY(III) CHLORIDE IN HYDROCHLORIC ACID 5 MOL/L)
|
|
Sb
|
|
(1β,5β,8-anti)-8-Methyl-3β-(2-thienyl)-8-azabicyclo[3.2.1]octane-2β-carboxylic acid methyl ester
|
|
|
|
Antimonic acid hydrogen=dipotassium salt
|
|
|
|
(1β,4β,7-anti)-7-(4-Methoxyphenyl)bicyclo[2.2.1]hept-2-en-7-ol
|
13118-72-4
|
C14H16O2
|
|
(1β,5β,8-anti)-8-Methyl-3β-[4-trifluoromethylphenyl]-8-azabicyclo[3.2.1]octane-2β-carboxylic acid methyl ester
|
|
|
|
(1β,5β,8-anti)-8-Methyl-3β-[4-(aminocarbonylmethyl)phenyl]-8-azabicyclo[3.2.1]octane-2β-carboxylic acid methyl ester
|
|
|
|
Antimony(V) telluride
|
|
Sb2Te5
|
|
Antimycin A2b
|
|
|
|
(1β,5β,8-anti)-8-Methyl-3β-[4-bromophenyl]-8-azabicyclo[3.2.1]octane-2β-carboxylic acid methyl ester
|
|
|
|
Antimycin A4b
|
|
|
|
(1β,5β,8-anti)-8-Methyl-3β-[4-nitrophenyl]-8-azabicyclo[3.2.1]octane-2β-carboxylic acid methyl ester
|
|
|
|
Antimony sulfide
|
12627-52-0
|
Unspecified
|
|
(1β,5β,8-anti)-8-Methyl-3β-[4-methylphenyl]-8-azabicyclo[3.2.1]octane-2β-carboxylic acid methyl ester
|
|
|
|
(+)-Antimycin A3a
|
|
|
|
(1β,5β,8-anti)-8-Methyl-3β-[phenyl]-8-azabicyclo[3.2.1]octane-2β-carboxylic acid methyl ester
|
|
|
|
(1β,5β,8-anti)-8-Methyl-3β-[4-(2-aminocarbonylethyl)phenyl]-8-azabicyclo[3.2.1]octane-2β-carboxylic acid methyl ester
|
|
|
|
Antimonic acid tripotassium salt
|
|
K3O4Sb
|
|
Antimonic acid hydrogen=nickel(II) salt
|
|
H3Ni3O8Sb2
|
|
Antimonic acid dihydrogen=potassium salt
|
|
|
|
Antimycin A1a
|
|
|
|
Antimycin A1b
|
116095-18-2
|
C28H40N2O9
|
|
Antimonic acid dihydrogen=sodium salt
|
|
|
|
Antimony, plasma standard solution, Specpure|r, Sb 10,000^mg/ml
|
|
Sb
|
|
Antimony tin oxide, NanoTek|r S1200W, 50% in H{2}O, colloidal dispersion
|
|
Sb2O5SnO21090wt
|
|
Antimony, Oil based standard solution, Specpure|r, Sb 1000^mg/g
|
|
|
|
Antimony, plasma standard solution, Specpure|r, Sb 1000^mg/ml
|
|
Sb
|
|
Antimony, Oil based standard solution, Specpure|r, Sb 5000^mg/g
|
|
|
|
Antimony tin oxide, NanoTek|r, 99.5%
|
|
|
|
Antimony, AAS standard solution, Specpure|r, Sb 1000^mg/ml
|
|
Sb
|